You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,544,364


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,544,364
Title:Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
Abstract:Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.
Inventor(s): Judice; J. Kevin (El Granada, CA), Shaw; Jeng-Pyng (Saratoga, CA), Mu; YongQi (Los Altos, CA), Conner; Michael W. (Half Moon Bay, CA), Pace; John L. (San Anselmo, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Application Number:11/410,597
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,544,364

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 7,544,364, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 7,544,364, titled "Method and System for Fast Access to Advanced Visualization of Medical Scans," was granted on June 9, 2009. This patent is part of a family of patents related to the visualization of medical scans, such as MRI and CT scans.

Claims Analysis

Claim Structure

The patent includes multiple claims, each defining a specific aspect of the invention. Claims can be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Scope

The claims of U.S. Patent 7,544,364 generally relate to methods and systems for accessing and visualizing medical scan data. Here are some key points:

  • Independent Claims: These claims define the core invention, such as the method for fast access to advanced visualization of medical scans using a dedicated web portal.
  • Dependent Claims: These claims add specific limitations to the independent claims, such as the use of particular algorithms or data compression techniques to enhance the visualization process[2].

Patent Eligibility

Patent eligibility is a critical aspect, especially under 35 U.S.C. § 101. The Alice test, a two-step framework, is used to determine if a patent claim is directed to patent-ineligible subject matter.

Alice Step One

This step determines whether the claims are directed to an abstract idea. In the case of U.S. Patent 7,544,364, the claims might be scrutinized for whether they are merely abstract ideas or if they provide an inventive step that transforms the abstract idea into a patent-eligible invention. For example, if the claims are deemed to be directed to the abstract idea of "retrieving user-requested, remotely stored information," they may face challenges under this step[2].

Alice Step Two

If the claims pass the first step, the second step examines whether the claims contain an inventive concept that transforms the abstract idea into something more. This involves looking at the character of the claims as a whole to determine if there is an inventive step beyond the abstract idea. For U.S. Patent 7,544,364, the focus would be on whether the specific methods and systems described add a significant inventive step over prior art[2].

Patent Landscape

Prior Art and Related Patents

Understanding the prior art and related patents is essential for assessing the novelty and non-obviousness of the invention. The patent landscape includes other patents and publications related to medical scan visualization. For instance, the European Patent Office's esp@cenet and the World Intellectual Property Organization's PATENTSCOPE databases can be used to search for prior art and related international patent applications[1][4].

Global Dossier and International Search

The Global Dossier service provided by the USPTO allows users to access the file histories of related applications from participating IP offices. This can help in identifying the patent family and related applications filed in other jurisdictions, which is crucial for understanding the global patent landscape[4].

Inventorship and Ownership

Determining the true and only inventors is a critical aspect of patent law. U.S. patent law requires that the inventors listed on the patent application are those who conceived the idea and reduced it to practice. Misidentification of inventors can lead to patent invalidity[5].

Search and Analysis Tools

Several tools are available for searching and analyzing patents:

  • Patent Public Search: This tool provides enhanced access to prior art and is useful for conducting preliminary patent searches[4].
  • PATENTSCOPE: This database offers full-text search of published international patent applications and machine translations for some documents[1].
  • Common Citation Document (CCD): This application consolidates prior art cited by participating offices, helping to visualize search results for the same invention on a single page[4].

Metrics for Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics can provide insights into the breadth and clarity of the patent claims. For example, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Practical Implications

Understanding the scope and claims of U.S. Patent 7,544,364 is vital for several reasons:

  • Infringement Analysis: To determine whether a product or service infringes on the patent, one must carefully analyze the claims and the scope of the invention.
  • Licensing and Litigation: The clarity and breadth of the claims can significantly impact licensing negotiations and litigation outcomes.
  • Innovation and Competition: Knowing the patent landscape helps innovators to avoid infringing on existing patents and to identify areas for further innovation.

Key Takeaways

  • Claims Analysis: Carefully review the independent and dependent claims to understand the core invention and its limitations.
  • Patent Eligibility: Ensure that the claims pass the Alice test to be considered patent-eligible.
  • Patent Landscape: Use global search tools to identify prior art and related patents.
  • Inventorship: Correctly identify the true and only inventors to avoid patent invalidity.
  • Metrics for Scope: Use metrics like independent claim length and count to assess the breadth and clarity of the patent.

FAQs

Q: What is the main focus of U.S. Patent 7,544,364? A: The main focus is on methods and systems for fast access to advanced visualization of medical scans using a dedicated web portal.

Q: How do you determine if a patent claim is patent-eligible under 35 U.S.C. § 101? A: Use the Alice test, a two-step framework that determines whether the claims are directed to an abstract idea and if they contain an inventive concept.

Q: What tools can be used to search for prior art and related international patent applications? A: Tools like the USPTO's Patent Public Search, PATENTSCOPE, and the Global Dossier service can be used.

Q: Why is correct inventorship important in patent law? A: Correct inventorship is crucial to avoid patent invalidity, as misidentification of inventors can lead to legal issues.

Q: How can the scope of a patent be measured? A: Metrics such as independent claim length and independent claim count can be used to measure the scope and clarity of the patent claims.

Sources

  1. Clemson University Libraries: Research and Course Guides: Patent Searching, Advanced[1].
  2. United States Court of Appeals for the Federal Circuit: AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC.[2].
  3. SSRN: Patent Claims and Patent Scope[3].
  4. United States Patent and Trademark Office: Search for patents[4].
  5. Oregon State University: Determining Inventorship for US Patent Applications[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,544,364

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,544,364

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1292612 ⤷  Subscribe C300507 Netherlands ⤷  Subscribe
European Patent Office 1292612 ⤷  Subscribe CA 2011 00033 Denmark ⤷  Subscribe
European Patent Office 1292612 ⤷  Subscribe 91908 Luxembourg ⤷  Subscribe
European Patent Office 1292612 ⤷  Subscribe PA2012002 Lithuania ⤷  Subscribe
European Patent Office 1292612 ⤷  Subscribe 1190036-2 Sweden ⤷  Subscribe
European Patent Office 1292612 ⤷  Subscribe 11C0051 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.